Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Open in API
Filings indexed 2,816 across all filing types
Latest filing 2024-05-07 Share Issue/Capital Cha…
Country DK Denmark
Listing CO GMAB

About Genmab

https://www.genmab.com/

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change Classification · 1% confidence The document is a company announcement regarding a capital increase resulting from the exercise of employee warrants. It details the number of shares issued, the subscription price, and the impact on total share capital. This falls under the category of share issuance and capital changes. While it mentions an attachment, the text itself provides the full details of the transaction, making it a primary announcement of a capital change rather than just a report publication announcement.
2024-05-07 Danish
6-K
Foreign Filer Report
2024-05-06 English
Transaction in Own Shares 2024
Transaction in Own Shares Classification · 1% confidence The document is explicitly titled "Transactions in Connection with Share Buy-back Program" and details the number of shares bought back daily between April 29, 2024, and May 3, 2024, under a previously announced program. This activity—the company purchasing its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. The document is a formal company announcement detailing these specific transactions, not just a general regulatory filing or a report announcement.
2024-05-06 English
Transactions in Connection with Share Buy-back Program
Regulatory Filings
2024-05-06 Danish
Transactions in Connection with Share Buy-back Program
Transaction in Own Shares Classification · 1% confidence The document is a company announcement detailing specific transactions executed under a share buy-back program. It provides a table of daily share repurchases, average prices, and total values, and explicitly mentions the program's compliance with the 'Safe Harbour Regulation'. Since the document reports on the company buying back its own shares, it falls under the 'Transaction in Own Shares' category.
2024-05-06 Danish
6-K
Foreign Filer Report
2024-05-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.